FDA Warns GLP-1 Maker Over Failure to Properly Report Deaths, Strokes

(MedPage Today) — The FDA issued a warning letter to Novo Nordisk for failing to report and investigate potentially serious side effects associated with its popular GLP-1 medications.
In a letter dated March 5 and made public on Tuesday, the…

Source link : https://www.medpagetoday.com/publichealthpolicy/fdageneral/120262

Author :

Publish date : 2026-03-11 21:11:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

FDA Warns GLP-1 Maker Over Failure to Properly Report Deaths, Strokes

Drug Cuts Treatment Modifications From Chemotherapy-Induced Thrombocytopenia

Traditional Medicare Enrollees Paid Billions More in Premiums Due to MA Overpayments

Related Posts

Inhaled Vasodilator Slows Lung Function Decline in Idiopathic Pulmonary Fibrosis

Goodbye FAERS? FDA Launches New Combined Adverse Event Database

Lead Suits Cut Physician Radiation Exposure for Interventional Cardiology Cases

Traditional Medicare Enrollees Paid Billions More in Premiums Due to MA Overpayments

Apixaban Snags a Win in Head-to-Head Trial of Direct Oral Anticoagulants

Drug Cuts Treatment Modifications From Chemotherapy-Induced Thrombocytopenia

Inhaled Vasodilator Slows Lung Function Decline in Idiopathic Pulmonary Fibrosis

Goodbye FAERS? FDA Launches New Combined Adverse Event Database

Lead Suits Cut Physician Radiation Exposure for Interventional Cardiology Cases

Traditional Medicare Enrollees Paid Billions More in Premiums Due to MA Overpayments

FDA Warns GLP-1 Maker Over Failure to Properly Report Deaths, Strokes

Apixaban Snags a Win in Head-to-Head Trial of Direct Oral Anticoagulants

Drug Cuts Treatment Modifications From Chemotherapy-Induced Thrombocytopenia

GLP-1 Drugs May Benefit Cancer Patients With Brain Lesions

Categories

Archives